Endovascular treatment strategy, technique, and outcomes for dural arteriovenous fistulas of the marginal sinus region.
coil
fistula
liquid embolic material
posterior fossa
technique
Journal
Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
28
02
2021
accepted:
11
05
2021
pubmed:
28
5
2021
medline:
21
1
2022
entrez:
27
5
2021
Statut:
ppublish
Résumé
Dural arteriovenous fistulas (AVF) of the foramen magnum region (FMR) are technically challenging lesions to treat. Transvenous (TV), transarterial (TA), and surgical approaches have been described, but the optimum treatment strategy is not defined. To report treatment strategies and outcomes for FMR-AVF at a single, high-volume referral center. A retrospective review from January 2010 to August 2020 identified patients with FMR-AVF at a single referral center. Angiographic features, treatment (observation, endovascular, surgical), and follow-up of angiographic and clinical results were recorded. The technical aspects of TV embolization are then presented in detail. 29 FMR-AVF were identified in 28 patients. Of these, 24/29 (82.8%) were treated and 5/29 (17.2%) were observed. Treatment was endovascular in 21/24 (87.5%), combined (endovascular+surgical) in 2/24 (8.3%), and surgical in 1/24 (4.2%). Endovascular treatments were 76.2% TV, 14.3% TA, and 9.5% combined TV/TA. Sufficient follow-up data were available for 20/28 (71.4%) with mean follow-up of 16.8 months. No AVF recurrence was seen for TA/TV, combined endovascular/surgical, or surgical groups, and there was one recurrence (7.1%) in the TV group. Symptomatic improvement was seen in all groups: TV (71.4% complete, 28.6% partial), TA (66.7% complete, 33.3% no follow-up), TV+TA (100% partial), endovascular/surgical (100% complete), and surgical (100% partial). Minor non-neurologic complications included 1/14 (7.1%) in the TV group and 1/3 (33.3%) in the TA/TV group. Endovascular treatment is safe and effective for most FMR-AVF. TV embolization has a high cure rate with few complications.
Sections du résumé
BACKGROUND
BACKGROUND
Dural arteriovenous fistulas (AVF) of the foramen magnum region (FMR) are technically challenging lesions to treat. Transvenous (TV), transarterial (TA), and surgical approaches have been described, but the optimum treatment strategy is not defined.
OBJECTIVE
OBJECTIVE
To report treatment strategies and outcomes for FMR-AVF at a single, high-volume referral center.
METHODS
METHODS
A retrospective review from January 2010 to August 2020 identified patients with FMR-AVF at a single referral center. Angiographic features, treatment (observation, endovascular, surgical), and follow-up of angiographic and clinical results were recorded. The technical aspects of TV embolization are then presented in detail.
RESULTS
RESULTS
29 FMR-AVF were identified in 28 patients. Of these, 24/29 (82.8%) were treated and 5/29 (17.2%) were observed. Treatment was endovascular in 21/24 (87.5%), combined (endovascular+surgical) in 2/24 (8.3%), and surgical in 1/24 (4.2%). Endovascular treatments were 76.2% TV, 14.3% TA, and 9.5% combined TV/TA. Sufficient follow-up data were available for 20/28 (71.4%) with mean follow-up of 16.8 months. No AVF recurrence was seen for TA/TV, combined endovascular/surgical, or surgical groups, and there was one recurrence (7.1%) in the TV group. Symptomatic improvement was seen in all groups: TV (71.4% complete, 28.6% partial), TA (66.7% complete, 33.3% no follow-up), TV+TA (100% partial), endovascular/surgical (100% complete), and surgical (100% partial). Minor non-neurologic complications included 1/14 (7.1%) in the TV group and 1/3 (33.3%) in the TA/TV group.
CONCLUSION
CONCLUSIONS
Endovascular treatment is safe and effective for most FMR-AVF. TV embolization has a high cure rate with few complications.
Identifiants
pubmed: 34039683
pii: neurintsurg-2021-017476
doi: 10.1136/neurintsurg-2021-017476
pmc: PMC8722448
mid: NIHMS1766401
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-159Subventions
Organisme : NHLBI NIH HHS
ID : R56 HL149124
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Neurointerv Surg. 2011 Sep;3(3):300-3
pubmed: 21990848
AJNR Am J Neuroradiol. 1997 Sep;18(8):1565-72
pubmed: 9296201
AJNR Am J Neuroradiol. 2002 Aug;23(7):1246-56
pubmed: 12169487
World Neurosurg. 2020 Dec;144:43-49
pubmed: 32805464
Br J Radiol. 2010 Oct;83(994):831-40
pubmed: 20647517
AJR Am J Roentgenol. 2021 Jun;216(6):1626-1633
pubmed: 32876481
Radiology. 1995 Mar;194(3):671-80
pubmed: 7862961
J Neurointerv Surg. 2017 Jan;9(1):97-101
pubmed: 27581042
J Neurointerv Surg. 2014 Mar;6(2):e13
pubmed: 23482712
Interv Neuroradiol. 2018 Aug;24(4):425-434
pubmed: 29726736
J Neurol. 2001 Mar;248(3):197-203
pubmed: 11355153
J Neurosurg. 2015 Apr;122(4):883-903
pubmed: 25415064
Childs Nerv Syst. 2019 May;35(5):747-751
pubmed: 30900022
AJNR Am J Neuroradiol. 2007 Sep;28(8):1599-601
pubmed: 17846219
J Neurointerv Surg. 2019 Feb;11(2):179-183
pubmed: 30054318
AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1915-8
pubmed: 17898196
Am J Phys Anthropol. 1986 Jul;70(3):311-24
pubmed: 3092672
Interv Neuroradiol. 2008 Sep 30;14(3):303-11
pubmed: 20557728
Interv Neuroradiol. 2016 Oct;22(5):584-9
pubmed: 27288404
Neuroradiology. 2008 Aug;50(8):715-21
pubmed: 18437370
J Neurosurg. 2013 Oct;119(4):955-60
pubmed: 23724984
Neuroradiology. 2012 Feb;54(2):163-9
pubmed: 21369779
J Neurosurg. 2006 Mar;104(3):429-31
pubmed: 16572657
Surg Neurol. 1985 Sep;24(3):293-352
pubmed: 4023912
Interv Neuroradiol. 2007 Mar;13(1):59-66
pubmed: 20566131
Neurosurgery. 2005 Oct;57(4 Suppl):367-71; discussion 367-71
pubmed: 16234687
AJNR Am J Neuroradiol. 2005 Sep;26(8):1955-9
pubmed: 16155141
J Neurointerv Surg. 2020 Aug;12(8):733-741
pubmed: 31818970
AJNR Am J Neuroradiol. 1999 Nov-Dec;20(10):2016-20
pubmed: 10588137
Oper Neurosurg (Hagerstown). 2018 Sep 1;15(3):262-269
pubmed: 29126165
AJNR Am J Neuroradiol. 1994 Nov;15(10):1871-83
pubmed: 7863937
AJNR Am J Neuroradiol. 2002 Oct;23(9):1500-8
pubmed: 12372739